Collegium Pharma (COLL)

Apr 1, 2025, 8:00 AM EDT - 22 days ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 8:00 AM EDT - 27 days ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 17, 2025, 7:00 AM EDT - 5 weeks ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 10, 2025, 6:57 PM EDT - 6 weeks ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Mar 9, 2025, 4:07 AM EDT - 6 weeks ago

Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025

Mar 4, 2025, 8:00 AM EST - 7 weeks ago

Collegium to Participate in Upcoming Investor Conferences

Feb 27, 2025, 9:03 PM EST - 7 weeks ago

Collegium Pharmaceutical, Inc. (COLL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 7 weeks ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:00 AM EST - 2 months ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 8, 2025, 8:00 AM EST - 3 months ago

Collegium Provides 2025 Financial Guidance and Business Update

Nov 26, 2024, 8:00 AM EST - 5 months ago

Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion

Nov 14, 2024, 4:30 PM EST - 5 months ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 8, 2024, 12:30 AM EST - 5 months ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 5 months ago

Collegium Reports Record Third Quarter 2024 Financial Results

Aug 30, 2024, 8:00 AM EDT - 8 months ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 9:30 PM EDT - 9 months ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 9 months ago

Collegium Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 6:00 AM EDT - 9 months ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

May 29, 2024, 8:00 AM EDT - 11 months ago

Collegium to Participate in Jefferies Global Healthcare Conference

May 13, 2024, 8:00 AM EDT - 1 year ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 9, 2024, 7:32 PM EDT - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:02 PM EDT - 1 year ago

Collegium Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Mar 12, 2024, 5:00 AM EDT - 1 year ago

Top 10 Small-Cap Stocks (SA Quant)

ANIP APOG BASE BLBD GCT PLMR RAMP

Feb 22, 2024, 9:52 PM EST - 1 year ago

Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 4:09 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Feb 8, 2024, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Nov 27, 2023, 8:00 AM EST - 1 year ago

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Nov 7, 2023, 10:15 PM EST - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:01 PM EST - 1 year ago

Collegium Reports Third Quarter 2023 Financial Results

Oct 24, 2023, 2:59 PM EDT - 1 year ago

Collegium Pharmaceutical: Delivering On Promises

Oct 24, 2023, 8:00 AM EDT - 1 year ago

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

Aug 28, 2023, 8:00 AM EDT - 1 year ago

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Aug 24, 2023, 8:00 AM EDT - 1 year ago

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

Aug 12, 2023, 5:25 AM EDT - 1 year ago

Collegium Pharmaceutical: Pipeline Continues As Share Buyback Initiates

Aug 11, 2023, 11:20 AM EDT - 1 year ago

With 30% Returns On Capital Deployed At 4.4x Earnings, Collegium Is A Buy

Aug 7, 2023, 7:30 AM EDT - 1 year ago

Collegium Announces $50 Million Accelerated Share Repurchase Program

Aug 4, 2023, 4:50 PM EDT - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:01 PM EDT - 1 year ago

Collegium Reports Record 1H'23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

Jul 20, 2023, 8:00 AM EDT - 1 year ago

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Collegium to Participate in Jefferies Healthcare Conference

May 25, 2023, 8:14 AM EDT - 2 years ago

Collegium: Turning More Constructive, Especially At 4.4x Earnings

May 6, 2023, 10:16 PM EDT - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:01 PM EDT - 2 years ago

Collegium Reports First Quarter 2023 Financial Results

Apr 20, 2023, 8:00 AM EDT - 2 years ago

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

Apr 11, 2023, 8:00 AM EDT - 2 years ago

Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference

Feb 23, 2023, 10:07 PM EST - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q4 2022 Earnings Call Transcript

Feb 23, 2023, 4:01 PM EST - 2 years ago

Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results

Feb 7, 2023, 9:54 PM EST - 2 years ago

Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering